<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04798118</url>
  </required_header>
  <id_info>
    <org_study_id>Toilet Bronchoscope</org_study_id>
    <nct_id>NCT04798118</nct_id>
  </id_info>
  <brief_title>Role of Toilet Bronchoscopy in RICU</brief_title>
  <official_title>A Study on Toilet Bronchoscopy In Respiratory ICU, Assiut University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Toilet bronchoscopy is a potentially therapeutic intervention to aspirate retained secretions&#xD;
      within the endotracheal tube and airways and revert atelectasis. Aspiration of airway&#xD;
      secretions is the most common indication to perform a therapeutic bronchoscopy in the&#xD;
      intensive care unit (ICU) .&#xD;
&#xD;
      Toilet bronchoscopy is particularly beneficial when retained secretions are visible during&#xD;
      the procedure and when air-bronchograms are not present at the chest radiograph. It is also&#xD;
      beneficial when there is an indication to reverse lobar atelectasis, rather than simply to&#xD;
      remove accumulated mucus.&#xD;
&#xD;
      Toilet bronchoscopy is used in lobar and complete lung collapse in mechanically ventilated&#xD;
      patients who fail to respond to treatments such as physiotherapy or recruitment manoeuvres.&#xD;
&#xD;
      The success rates (defined as radiographic improvement on chest X-ray [CXR] or an improved&#xD;
      PaO2/PAO2 ratio) in the ICU patient population had.&#xD;
&#xD;
      Patients with acute hypoxaemic respiratory failure may already be on non-invasive ventilation&#xD;
      (NIV), or require NIV preemptively for Fiberoptic Bronchoscopy (FB). These patients should be&#xD;
      considered high risk for requiring intubation post-procedure; therefore, Fiberoptic&#xD;
      Bronchoscopy should be performed by an experienced operator in a setting allowing facilities&#xD;
      to safely secure the airways. NIV with early therapeutic FB rather than mechanical&#xD;
      ventilation can help avoid intubation and reduce tracheostomy rate. Hospital mortality,&#xD;
      duration of ventilation, and hospital stay remain similar&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim Of Work To study the value of toilet bronchoscopy in&#xD;
&#xD;
        1. Mechanical ventilated patients with chest disease and copious secretion.&#xD;
&#xD;
        2. Mechanical ventilated patients diagnosed to have atelectasis radiologically.&#xD;
&#xD;
        3. Patients on non-invasive ventilation with chest diseases and copious secretion&#xD;
&#xD;
        4. Compare Different types of mucolytics during toilet bronchoscopy in mechanically&#xD;
           ventilated patients.&#xD;
&#xD;
        5. Compare Different types of sedations during toilet bronchoscopy in mechanically&#xD;
           ventilated patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1- percent of patients develop radiological improvement</measure>
    <time_frame>12 months</time_frame>
    <description>assessed improvement of atelectasis by chest x-ray or HRCT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>2- improvement of hypoxemia</measure>
    <time_frame>12months</time_frame>
    <description>assessed by sao2/fio2 or pao2/fio2 before and after procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>3-Lung mechanics reduction post procedure in mechanical ventilated patients</measure>
    <time_frame>12 months</time_frame>
    <description>resistance measured by cm H2o /Liter/ second</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lung mechanics improvement post procedure in mechanical ventilated patients</measure>
    <time_frame>12 months</time_frame>
    <description>assessed by static compliance measured by ml/cm H2o</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay</measure>
    <time_frame>12 months</time_frame>
    <description>measured by days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>12 months</time_frame>
    <description>measured by days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of complications</measure>
    <time_frame>12 months</time_frame>
    <description>developed or not</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-Hospital mortality</measure>
    <time_frame>12 months</time_frame>
    <description>percent in each group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>COPD</condition>
  <condition>Asthma</condition>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>group treated with toilet bronchoscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Toilet bronchoscopy will be done as supportive care to sixty five (COPD,asthma,cystic bronchiectasis ) mechanically ventilated patients who fulfill the following criteria :&#xD;
Copious secretion&#xD;
Radiologically diagnosed atelectasis and absent air-bronchograms. Standard care of treatment will be carried out then assessment of a radiological, gasometric improvement and lung mechanics changes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group treated with standered care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sixty five (COPD,asthma,cystic bronchiectasis ) mechanically ventilated patients who fulfill the following criteria :&#xD;
Copious secretion&#xD;
Radiologically diagnosed atelectasis and absent air-bronchograms. Standard care of treatment will be carried out then assessment of a radiological, gasometric improvement and lung mechanics changes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>toilet bronchoscope</intervention_name>
    <description>Toilet bronchoscopy will be done by infuse normal saline or N-Acetylcysteine with a syringe, observing the flow of saline at the distal tip of the bronchoscope then suction intra bronchial visible secretions during the procedure and also suction of specific lobe guided by radiological finding in the patient A chest X-ray will be routinely performed prior and after the procedure, HRCT is mandatory when chest x-ray not clearly defining the collapse monitoring of heart rate, oxygen saturation, ventilator parameters, and arterial blood pressure will be done</description>
    <arm_group_label>group treated with standered care</arm_group_label>
    <arm_group_label>group treated with toilet bronchoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Patients on mechanical ventilation with underlying dieases that are characterized&#xD;
             with mucus overproduction such as asthma, chronic obstructive pulmonary disease&#xD;
             (COPD), bronchiectasis, and cystic fibrosis.&#xD;
&#xD;
               -  Patients on mechanical ventilation with visible large amount of sputum during&#xD;
                  suction in order to clear secretions.&#xD;
&#xD;
               -  Patients on mechanical ventilation with radiologically diagnosed atelectasis and&#xD;
                  absent air-bronchograms&#xD;
&#xD;
               -  Patient on NIV who was benefit from toilet bronchoscopy to clear retained&#xD;
                  secretion.&#xD;
&#xD;
        Exclusion Criteria:Absolute contraindications&#xD;
&#xD;
          -  Absence of consent from the patient or his/her representative.&#xD;
&#xD;
          -  Inability to adequately oxygenate the patient during the procedure.&#xD;
&#xD;
          -  Current myocardial ischaemia.&#xD;
&#xD;
          -  Significant haemodynamic instability.&#xD;
&#xD;
          -  Life-threatening cardiac arrhythmias.&#xD;
&#xD;
          -  Current significant bronchospasm.&#xD;
&#xD;
          -  Undrained pneumothorax.&#xD;
&#xD;
        Relative contraindications&#xD;
&#xD;
          -  Thrombocytopenia (platelet count ≤50,000 platelets/mm).&#xD;
&#xD;
          -  INR of 2 or greater, or an elevated PTT.&#xD;
&#xD;
          -  BUN &gt;30.&#xD;
&#xD;
          -  severe tracheal obstruction.&#xD;
&#xD;
          -  Recent myocardial ischaemia and/or unstable angina.&#xD;
&#xD;
          -  Intracranial hypertension.&#xD;
&#xD;
          -  Poorly-controlled heart failure.&#xD;
&#xD;
          -  Recent oral intake.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saher f youssif</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shaimaa A Mohammed, MD</last_name>
    <phone>01016599093</phone>
    <email>drshimaalimohammed@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saher f youssif</last_name>
    <phone>01002976708</phone>
    <email>Saherfr2009@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assuit university hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Shimaa A Mohammed</last_name>
      <phone>01016599093</phone>
      <email>drshimaalimohammed@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Marini JJ, Pierson DJ, Hudson LD. Acute lobar atelectasis: a prospective comparison of fiberoptic bronchoscopy and respiratory therapy. Am Rev Respir Dis. 1979 Jun;119(6):971-8.</citation>
    <PMID>453712</PMID>
  </reference>
  <reference>
    <citation>Snow N, Lucas AE. Bronchoscopy in the critically ill surgical patient. Am Surg. 1984 Aug;50(8):441-5.</citation>
    <PMID>6465691</PMID>
  </reference>
  <reference>
    <citation>Kreider ME, Lipson DA. Bronchoscopy for atelectasis in the ICU: a case report and review of the literature. Chest. 2003 Jul;124(1):344-50. Review.</citation>
    <PMID>12853543</PMID>
  </reference>
  <reference>
    <citation>Jelic S, Cunningham JA, Factor P. Clinical review: airway hygiene in the intensive care unit. Crit Care. 2008;12(2):209. doi: 10.1186/cc6830. Epub 2008 Mar 31. Review.</citation>
    <PMID>18423061</PMID>
  </reference>
  <reference>
    <citation>José RJ, Shaefi S, Navani N. Sedation for flexible bronchoscopy: current and emerging evidence. Eur Respir Rev. 2013 Jun 1;22(128):106-16. doi: 10.1183/09059180.00006412. Review.</citation>
    <PMID>23728864</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Shaimaa Ali Mohammed</investigator_full_name>
    <investigator_title>Assistant lecturer,chest department and tuberculosis</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

